Sugimoto M, Dannenberg A M, Wahl L M, Ettinger W H, Hastie A T, Daniels D C, Thomas C R, Demoulin-Brahy L
Am J Pathol. 1978 Mar;90(3):583-607.
To evaluate extracellular hydrolytic enzymes in an in vivo system, plastic chambers were glued over rabbit dermal BCG lesions in various stages of development, after the central epithelium was removed with a scalpel. They were filled with tissue culture medium and left in place 2 days. The following enzymes in the fluid were assayed: collagenase (an enzyme secreted but not stored in macrophages); lysozyme (both secreted and stored); DNase and RNase (released on cell death and possibly regurgitated but not secreted); and, as a control, lactic dehydrogenase (released only on cell death). Tissue sections were prepared and studied histologically for the type of cell infiltrate, for beta-galactosidase (our marker enzyme for macrophage activation), and for necrosis. At 11 and 18 days of age the BCG lesions were largest and the number of activated macrophages in the chamber beds was highest. At this time the levels of the five enzymes assayed in the chamber fluids reached their peaks, tuberculin hypersensitivity was well developed, and the bacilli components would still be plentiful. In general, the chamber fluids from 11- and 18-day BCG lesions contained higher enzyme levels than chamber fluids from tuberculin reactions. Active collagenase was only detected in fluids from such BCG lesions. Evidently, the serum in the chamber fluids was sufficient to inhibit the lower amounts of collagenase probably released from smaller BCG lesions and tuberculin reactions (and from the 2-week polystyrene lesions that were also evaluated). These studies demonstrate that in chronic inflammatory reactions, both acid-acting and neutral-acting hydrolytic enzymes are released extracellularly. Tissue components would be hydrolyzed locally wherever the acid-acting hydrolytic enzymes encounter a drop in pH and wherever the concentration of neutral-acting hydrolytic enzymes exceeds the concentration of their inhibitors.
为了在体内系统中评估细胞外水解酶,在用手术刀切除中央上皮后,将塑料小室粘贴在处于不同发育阶段的兔皮肤卡介苗(BCG)病灶上。小室中充满组织培养基,并放置2天。对液体中的以下酶进行了检测:胶原酶(一种分泌但不储存在巨噬细胞中的酶);溶菌酶(既分泌又储存);DNA酶和RNA酶(在细胞死亡时释放,可能是反刍但非分泌产生);作为对照,乳酸脱氢酶(仅在细胞死亡时释放)。制备组织切片并进行组织学研究,观察细胞浸润类型、β-半乳糖苷酶(我们用于巨噬细胞活化的标记酶)以及坏死情况。在11日龄和18日龄时,卡介苗病灶最大,小室床中活化巨噬细胞的数量最高。此时,在小室液体中检测的五种酶的水平达到峰值,结核菌素超敏反应充分发展,并且杆菌成分仍然丰富。一般来说,来自11日龄和18日龄卡介苗病灶的小室液体中的酶水平高于来自结核菌素反应的小室液体。仅在来自此类卡介苗病灶的液体中检测到活性胶原酶。显然,小室液体中的血清足以抑制可能从较小的卡介苗病灶和结核菌素反应(以及也进行了评估的2周聚苯乙烯病灶)释放的较低量的胶原酶。这些研究表明,在慢性炎症反应中,酸性作用和中性作用的水解酶都会在细胞外释放。无论酸性作用的水解酶在哪里遇到pH值下降,以及中性作用的水解酶浓度在哪里超过其抑制剂的浓度,组织成分都会在局部被水解。